2-Bromopyridines as Versatile Synthons for Heteroarylated 2-Pyridones via Ru(II)-Mediated Domino C-O/C-N/C-C Bond Formation Reactions. [PDF]
Drev M +6 more
europepmc +1 more source
Prevalence of Potentially Inappropriate Apixaban Prescribing Within a Single-Centre Tertiary Hospital. [PDF]
Creeper KJ +5 more
europepmc +1 more source
Crystal structure, spectroscopy, DFT, and thermal studies of 3-cyano-2(1H)-pyridones as potential anticancer agents. [PDF]
Hurtado-Rodríguez D +5 more
europepmc +1 more source
Recurrent Stroke and Progression of Left Ventricular Thrombus During Apixaban Therapy in a Patient with Severe Ischemic Cardiomyopathy: A Case Report. [PDF]
Babonji A +4 more
europepmc +1 more source
Bone Changes With Long-Acting Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention in Cisgender Men and Transgender Women: HPTN 083. [PDF]
Brown TT +12 more
europepmc +1 more source
Compound adsorption device in pathogen reduction technology removes multiple drugs from plasma components. [PDF]
Greenwall B, Reeder K, Anani WQ.
europepmc +1 more source
Direct Synthesis of Benzhydryl-Functionalized 3,4-Dihydropyridin-2-ones from 2-Pyridones and Their Use in the Formation of Bridged δ-Lactams. [PDF]
Myk ZM, Sośnicki JG, Struk Ł.
europepmc +1 more source
Successful treatment of osimertinib-resistant EGFR-mutant NSCLC with acquired BRAF V600E mutation using triple combination therapy: a case report with pathological confirmation. [PDF]
Lin M, Chen X, Lin F, Yang Y.
europepmc +1 more source
Metal-Free Cascade Formation of C-C and C-N Bond for the Construction of 3-Cyano-2-Pyridones with Insecticidal Properties. [PDF]
Tang Y +5 more
europepmc +1 more source
Dolutegravir concentrations in children receiving 3-month weekly isoniazid and rifapentine (3HP) for tuberculosis prevention. [PDF]
Madzime RJ +13 more
europepmc +1 more source

